Microadenomatosis of the endocrine pancreas in patients with and without the multiple endocrine neoplasia type 1 syndrome.
about
Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversiesPancreatic endocrine neoplasms: a current update on genetics and imaging.Current knowledge on the sensitivity of the (68)Ga-somatostatin receptor positron emission tomography and the SUVmax reference range for management of pancreatic neuroendocrine tumoursMEN1, MEN4, and Carney Complex: Pathology and Molecular Genetics[MEN1 gastrinoma: routine duodenal exploration!].Age-related penetrance of endocrine tumours in multiple endocrine neoplasia type 1 (MEN1): a multicentre study of 258 gene carriers.Long-term Follow-up of MEN1 Patients Who Do Not Have Initial Surgery for Small ≤2 cm Nonfunctioning Pancreatic Neuroendocrine Tumors, an AFCE and GTE Study: Association Francophone de Chirurgie Endocrinienne & Groupe d'Etude des Tumeurs Endocrines.Sporadic versus hereditary gastrinomas of the duodenum and pancreas: distinct clinico-pathological and epidemiological features.Insulin secretion and insulin-producing tumorsHereditary pancreatic cancer: related syndromes and clinical perspective.Loss of Progesterone Receptor Expression Is an Early Tumorigenesis Event Associated with Tumor Progression and Shorter Survival in Pancreatic Neuroendocrine Tumor Patients.ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors.Glucagon receptor gene mutations with hyperglucagonemia but without the glucagonoma syndrome.Proliferation rates of multiple endocrine neoplasia type 1 (MEN1)-associated tumors.Allelic deletion of the MEN1 gene in duodenal gastrin and somatostatin cell neoplasms and their precursor lesions.Multiple Endocrine Neoplasia: Genetics and Clinical Management.Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors.ActivinB Is Induced in Insulinoma To Promote Tumor Plasticity through a β-Cell-Induced DedifferentiationA prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: identification of risk factorsComparison of WHO Classifications (2004, 2010), the Hochwald grading system, and AJCC and ENETS staging systems in predicting prognosis in locoregional well-differentiated pancreatic neuroendocrine tumors.Endocrine precursor lesions and microadenomas of the duodenum and pancreas with and without MEN1: criteria, molecular concepts and clinical significance.Genetics of pancreatic neuroendocrine tumors: implications for the clinic.Diagnosis and Treatment of Gastrinomas in Multiple Endocrine Neoplasia Type 1 (MEN-1).Care for patients with multiple endocrine neoplasia type 1: the current evidence base.The diversity and commonalities of gastroenteropancreatic neuroendocrine tumors.Well-differentiated pancreatic neuroendocrine tumors: from genetics to therapy.Multiple endocrine neoplasia type 1 (MEN1).Neuroendocrine tumors of the pancreas: current concepts and controversies.Hyperplasia to neoplasia sequence of duodenal and pancreatic neuroendocrine diseases and pseudohyperplasia of the PP-cells in the pancreas.Pathology diagnosis of pancreatic neuroendocrine tumors.Determinants of surgical resection for pancreatic neuroendocrine tumors.Role of transcription factors in the transdifferentiation of pancreatic islet cells.Glucagonoma and the glucagonoma syndrome - cumulative experience with an elusive endocrine tumour.Syndromic versus non-syndromic sporadic gastrin-producing neuroendocrine tumors of the duodenum: comparison of pathological features and biological behavior.Pathogenesis of gastrinomas associated with multiple endocrine neoplasia type 1.Pathologic pancreatic endocrine cell hyperplasia.When should genetic testing be performed in patients with neuroendocrine tumours?MAFA missense mutation causes familial insulinomatosis and diabetes mellitus.Increased Expression of GLP-1R in Proliferating Islets of Men1 Mice is Detectable by [68Ga]Ga-DO3A-VS-Cys40-Exendin-4 /PET.Neuroendocrine Neoplasms: Dichotomy, Origin and Classifications.
P2860
Q24647838-4FC22D1E-11CC-4581-8CA9-33BE7C81BC69Q26852418-57AEBB2F-B44F-487F-94E6-7E7775A73772Q28071483-06C132C5-F4FD-4365-97EC-FA623853C307Q28088746-0D2764C2-A6E1-435F-8FC3-B47E2C55BC74Q30318104-69DA514D-F826-4934-8FBB-7768C2F28FE7Q30319804-ED078B0E-7B4B-4952-9AD8-5DB2E2E077D6Q30491060-6CBBAFB9-8D89-4301-A372-5C57E5A3F805Q33258694-AECE2AC1-6610-4A95-83A0-F6B312EE6C14Q33786707-26754DF6-41C8-46E2-8CBA-478F603D9158Q33851085-91361097-2AC7-455D-A57E-72E43AAF89EBQ33925601-8A004F2A-72C4-4FFA-97BF-4C629AD79F14Q34248466-D3702CED-3EC9-4126-A1A8-26A1B3768BABQ35334364-104B2076-1F0B-4EAA-B21C-E534F726A4BFQ35661980-CD0328D2-2E11-4361-9EA5-D7E5803E6456Q35929598-8C22ED91-3811-4C2D-9CDC-2ECFDED0D0E4Q36063577-F8744334-A88A-4214-A1BA-AE69E5B29BEFQ36541359-29A155B2-6111-4BCF-8376-DE2EB0E4D811Q36597253-5A999EFC-094B-4152-A70B-CB84C9ACA63BQ36661917-29616CB7-E277-4513-89F0-22A7E4CF7B35Q36843996-962ED199-43D8-4C46-9458-9BB441584F31Q36949646-159EBC22-FD26-4EED-8C01-00DD51B79BB6Q36960581-AE4F5E9E-C2CE-43AD-BABB-23162676DE63Q37016985-0CB41574-D678-4A7A-86FC-8DBA2628085AQ37808142-1E51145E-5964-4454-B33D-E7D219E2973CQ37832970-DDF0F4AA-61FE-4728-BE8A-BC84CE1A117AQ37981893-CAB4C6B9-7F00-45FE-93DD-D7345E84401DQ38070923-87BC7E4F-2651-4A97-A48C-8771639657AFQ38178882-8B3C31C8-DB10-4C26-9773-482FF7A50D7AQ38203466-FE6317D4-8833-4C6E-A757-CC54BE13EB65Q38340420-E2BEBDC4-ED22-4D7B-A931-B77ED9569865Q38378959-9DF38106-1ACA-4D01-A3E5-671120FE7907Q38384412-CD538125-7D33-4556-930F-67D4B793034EQ39267922-5319BD3A-F602-453F-9C8D-611AD31B6C68Q40229801-C98F516C-9CDF-446A-9604-2F73EFD70FA7Q42424883-2FF5D4D3-A7FB-4858-96F1-92D0FEBB313BQ42569689-FFCB16B7-7FCC-4F04-A415-01859071CDD8Q47921456-87A46481-679B-40D7-98E5-74D83E9018B7Q48232244-6A6CD429-61D2-4F64-A700-3765B2CD5F8AQ49165538-560CC580-7E67-4108-B30A-D703AC8CE150Q49612106-CCA81A39-32B8-4331-9182-CDD4661722DB
P2860
Microadenomatosis of the endocrine pancreas in patients with and without the multiple endocrine neoplasia type 1 syndrome.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Microadenomatosis of the endoc ...... ine neoplasia type 1 syndrome.
@ast
Microadenomatosis of the endoc ...... ine neoplasia type 1 syndrome.
@en
type
label
Microadenomatosis of the endoc ...... ine neoplasia type 1 syndrome.
@ast
Microadenomatosis of the endoc ...... ine neoplasia type 1 syndrome.
@en
prefLabel
Microadenomatosis of the endoc ...... ine neoplasia type 1 syndrome.
@ast
Microadenomatosis of the endoc ...... ine neoplasia type 1 syndrome.
@en
P2093
P1476
Microadenomatosis of the endoc ...... ine neoplasia type 1 syndrome.
@en
P2093
Andreas Raffel
Anne Couvelard
Aurel Perren
Christian A Koch
Eberhard Weihe
Juliane Bauersfeld
Martin Anlauf
Paul Komminoth
Philipp U Heitz
Philippe Ruszniewski
P304
P356
10.1097/01.PAS.0000194044.01104.25
P407
P577
2006-05-01T00:00:00Z